Tetrabenazinum

compositum chemicum

Tetrabenazinum est medicamentum in malis motuum hyperkineticis tractandis, ut morbo Huntington et dystoniis atque dyskinesia tardiva.

Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.

Tetrabenazinum
Cognitores
ChemSpider 5796
PubChem 6018
DrugBank DB04844
Natura chemica
Tetrabenazinum
Formula summarum C
19
H
27
NO
3
Massa molaris 317.427 g/mol
Natura pharmacologica
Codex ATC N07XX06 (WHO)
Metabolismus iecore (hepaticus)
Excretio renibus: 75%,
faecibus: 7-16%
Ad usum therapeuticum
Applicatio per os

Natura Tetrabenazini

recensere

Natura chemica

recensere

Tetrabenazinum est (IUPAC) (RR,SS)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo-[a]-chinolinum.

Massa molaris est 317.427 g/mol.

Natura pharmacologica

recensere

Pharmacodynamica

recensere

Tetrabenazinum receptoria dopamini obsidet inhibetque. Praeterea neurotransmissores monoaminergicos consumit.

Pharmacocinetica

recensere

Excretio est per imprimis urinas, minus per biles.

Effectus Tetrabenazini

recensere

Effectus secundarii

recensere

Exempli (!) sunt[1]:

Nexus interni

  1. Jankovic J., Beach J. (Feb 1997). "Long-term effects of tetrabenazine in hyperkinetic movement disorders". Neurology 48 (2): 385-62